KALA vs QRVO · $54.3M cap vs P/E 27, rev $3.68B
Kala Pharmaceuticals Inc (KALA) versus Qorvo Inc (QRVO) — a side-by-side from cached financials, not a winner call.
Kala Pharmaceuticals Inc (KALA) is a biotechnology company listed on NASDAQ.
Qorvo Inc (QRVO) is a semiconductors company listed on NASDAQ.
Latest reported KALA revenue for 2025-12-31 was $0. Net income was -$27.0M. KALA currently screens at market cap $54.3M.
Latest reported QRVO revenue for 2026-03-28 was $3.68B. Net income was $339.0M. Revenue was down 1.1% from 2025-03-29 to 2026-03-28. QRVO currently screens at market cap $8.54B and trailing P/E 26.8.
KALA currently screens at market cap $54.3M. QRVO currently screens at market cap $8.54B and trailing P/E 26.8.
Not investment advice. Open the KALA and QRVO stock pages for the full models.
Not investment advice.